Effect of Physiotherapeutic Interventions on Quality of Life in Patients With Chronic Low Back Pain. (Study 2) (CLBP)
Effects of a Multimodal Intervention Based on the 4 Times T Orthopedic Rehabilitation Decision Tree on the Quality of Life in Non-specific Chronic Low Back Pain.
연구 개요
상세 설명
The purpose of this small RCT is to investigate whether this is a good research design and procedure to measure the effect on QoL, PI and the AROM° in patients with NSP-CLBP. This after following an episode of 6 weeks twice a week physiotherapeutic back rehabilitation according to the 4MTOR®. The results in this research will also be analysed and reported. The research design and procedure will be useful when this small RCT shows that the 4MTOR® can positively influence the QoL,PI and the AROM° with a p value <α = 0.05 in NSP-CLBP patients.
Primary variable is the QoL these are measured using the EQ-5D-3L which consists of the EQ-5D-index and the EQ visual analogue scale (EQ-VAS). The EQ-5D-3L questionnaire is developed by Euroqol Group. Secondary outcome measures are the AROM° of the active trunk flexion and trunk extension measured with a bubble inclinometer. Also, the PI will be scored by the patient during flexion and extension by means of the Verbal Pain Scale scaled 0-10 (VRS). The outcomes will be measured within 12 weeks in all participants. The measurements take place during week 0 the baseline measurement (W0), week 3 the intermediate measurement (W3) week 7 the post measurement (W7) and finally week 12 follow up measurement (W12). All participants were fully informed for the research and agreed by signing the "informed consent" . The research was approved by the Committee of Medical Ethics University Hospital University of Brussels, B.U.N. 143201627110.
Inclusion and exclusion criteria. Participants are included when they meet the following criteria: NSP-CLBP from 12 weeks and longer that are continuously present (with and without recurrent complaints), Age between 20 and 60 years and not yet treated by the 4MTOR®. Participants are excluded when they meet the following criteria: Radiological disturbing pain beyond knee, extremely serious neurological disorder symptoms, overall malaise, spinal cord malignancy, unexplained weight loss, prolonged corticosteroid use, osteoporotic vertebral fracture, spondylitis ankylopoetics, spinal stenosis, rheumatic arthritis, vertebral fracture and severe deformity of the spinal cord.
Recruitment. Patients recruitment: The subjects are recruited from orthopedic hospitals departments in Utrecht the Netherlands. Participants will be asked if they want to refer NSP-CLBP patients for this research and by advertisement in an Dutch-language newspaper (Appendix II). Also, NSP-CLBP patients who applied for physical therapy were asked if they wanted to participate in this research. A call form has been prepared for this purpose (Appendix III). All subjects were asked if they would like to participate in this research. The subjects has been authorized to perform medical physiotherapeutic treatment. This has been done by signing a statement of agreement, as previously stated. Personal data will not be included in this research and are protected by researchers and the Committee of Medical Ethics University Hospital University of Brussels.
Therapist recruitment Experimental intervention group: This physiotherapist has been educated and qualified in the KNGF accredited multimodal intervention according to the 4MTOR®. The physiotherapist has at least 2 years of work experience with the use of the 4MTOR® decision tree.
Therapist recruitment SHAM intervention group: This is Health Care registered physiotherapist and has at least 3 years work experience and is familiar with the KNGF Low Back pain, 2013 guidelines (KNGF_LBP). Both therapists were informed about their work protocol and have agreed to the implementation of the interventions by signing an informed consent.
In the experimental group (EGR), the 4MTOR® treatment method will be used for LBP. This 4MTOR® uses the following steps in a decision tree: T1 Testing (Physiotherapeutic examination), T2 Triggering (Manual Techniques), T3 Taping (Elastic Tape) and T4 Training (medical rehabilitation exercises).
The participants in the Sham group (SGR) received a sham multimodal physiotherapeutic intervention as control intervention, in which Sham technique was applied. The interventions consisted of combining Sham manual interventions, elastic tapes according to Kaze32 and Evidence Based Practice Therapy (Appendix III). The protocol in the SGR follows the similar steps: Testing, Taping, Triggering and Training like the 4MTOR®.
Primary:
- EQ 5d-5L questionnaire
Secondary:
Thoracolumbo-pelvic flexion, inclinometry Thoracolumbo-pelvic extension, inclinometry (note 5 x for measurement errors) Isolated lumbar flexion, inclinometry Verbal pain score flexion, VRS 0-10 Verbal pain score extension, VRS 0-10
Research design. This research is a one way, Mixed, real experimental design One way design (Independent Groups variables). Mixed Design: Baseline Week 0 - Week 3 - Week 7-Week 12 Within groups: difference in time Between groups: difference between groups.
The sample analysis was performed for the RM-ANOVA using the Gpower © program. The RM-ANOVA power analysis with the following values: Power .95, Alpha 0.50, Sample size effect f2 = .24 resulted in a minimum of 40 participants. 20% will be added on the total N=48 for the possibility of dropouts. The CLBP participants are divided into two groups, each group holding twenty-five participants.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Robbert R.N. Amstel, MSc
- 전화번호: +31 0611763830
- 이메일: Robbert.Van.Amstel@vub.be
연구 연락처 백업
- 이름: Peter P Vaes, PhD
- 전화번호: +32 +322 477 43 26
- 이메일: pvaes@vub.be
연구 장소
-
-
Brussels
-
Jette, Brussels, 벨기에, 1090
- 모병
- Peter Vaes
-
연락하다:
- Robbert R.N. van Amstel, MSc
- 전화번호: +31 0611763830
- 이메일: Robbert.Van.Amstel@vub.be
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Participants are included when they meet the following criteria:
- NSP-CLBP from 12 weeks and longer that are continuously present (with and without recurrent complaints)
- Age between 20 and 60 years
- Not yet treated by the 4MTOR®.
Exclusion Criteria:
Participants are excluded when they meet the following criteria:
- Radiological disturbing pain beyond knee
- Extremely serious neurological disorder symptoms
- Overall malaise
- Spinal cord malignancy
- Unexplained weight loss
- Prolonged corticosteroid use
- Osteoporotic vertebral fracture
- Spondylitis ankylopoetics
- Spinal stenosis
- Rheumatic arthritis
- Vertebral fracture
- Severe deformity of the spinal cord
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 요인 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: experimental group (EGR)
Physical therapy intervention. In the experimental group (EGR), the 4MTOR® treatment method will be used for LBP. This 4MTOR® uses the following steps in a decision tree: T1 Testing (Physiotherapeutic examination), T2 Triggering (Manual Techniques), T3 Taping (Elastic Tape) and T4 Training (medical rehabilitation exercises). |
실험군(EGR)에서는 요통에 4MTOR® 처리 방법을 사용한다. 이 4MTOR®는 의사 결정 트리에서 다음 단계를 사용합니다: T1 테스트(물리 치료 검사), T2 트리거링(수동 기법), T3 테이핑(탄성 테이프) 및 T4 교육(의료 재활 운동). SGR의 참가자는 통제 개입으로 가짜 다중 모드 물리 치료 개입을 받았으며 여기에 가짜 기술이 적용되었습니다. 개입은 가짜 수동 개입, Kaze32에 따른 탄성 테이프 및 증거 기반 실습 요법(부록 III)을 결합하여 구성되었습니다. SGR의 프로토콜은 4MTOR®와 같은 테스트, 테이핑, 트리거링 및 교육과 같은 유사한 단계를 따릅니다. |
|
가짜 비교기: Sham group (SGR)
Physical therapy intervention. The participants in the SGR received a sham multimodal physiotherapeutic intervention as control intervention, in which Sham technique were applied. The interventions consisted of combining Sham manual interventions, elastic tapes according to Kaze and Evidence Based Practice Therapy. The protocol in the SGR follows the similar steps: Testing, Taping, Triggering and Training like the 4MTOR®. |
실험군(EGR)에서는 요통에 4MTOR® 처리 방법을 사용한다. 이 4MTOR®는 의사 결정 트리에서 다음 단계를 사용합니다: T1 테스트(물리 치료 검사), T2 트리거링(수동 기법), T3 테이핑(탄성 테이프) 및 T4 교육(의료 재활 운동). SGR의 참가자는 통제 개입으로 가짜 다중 모드 물리 치료 개입을 받았으며 여기에 가짜 기술이 적용되었습니다. 개입은 가짜 수동 개입, Kaze32에 따른 탄성 테이프 및 증거 기반 실습 요법(부록 III)을 결합하여 구성되었습니다. SGR의 프로토콜은 4MTOR®와 같은 테스트, 테이핑, 트리거링 및 교육과 같은 유사한 단계를 따릅니다. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
First measurment: Quality of life, EQ-5D-3L-index
기간: Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3)
|
The EQ-5D-3L-index will analyze the participants Quality of life (QoL). Each question in the EQ-5D-3L-index includes one dimension of QoL: mobility, self-care, daily activities, pain/discomfort & anxiety/depression. Each dimension has 3 levels ( having no problems, having some or moderate problems, being unable to do/having extreme problems) and gets a separate score.The scores can be combined in combination with an assessment of the health status they represent, this rating is expressed in weight or utility (1,000 = no problems at all) to (-0,329= extreme problems). Description of the QoL can be transformed into a QoL assessment by means of a formula. These ratings are based on judgments of the general population of all possible combinations of QoL on the different dimensions. An improvement in quality of life will be assumed when p<α=0.05. Within time: W0-W3 Between groups: EGR versus SGR. The results are shown for all variables in a table. |
Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3)
|
|
Second measurment: Quality of life, EQ-5D-3L-index
기간: Timespad registration: Week 3/intermediate measurement (W3), week 7/ post measurement (W7)
|
The EQ-5D-3L-index will analyze the participants Quality of life (QoL). Each question in the EQ-5D-3L-index includes one dimension of QoL: mobility, self-care, daily activities, pain/discomfort & anxiety/depression. Each dimension has 3 levels ( having no problems, having some or moderate problems, being unable to do/having extreme problems) and gets a separate score.The scores can be combined in combination with an assessment of the health status they represent, this rating is expressed in weight or utility (1,000 = no problems at all) to (-0,329= extreme problems). Description of the QoL can be transformed into a QoL assessment by means of a formula. These ratings are based on judgments of the general population of all possible combinations of QoL on the different dimensions. An improvement in quality of life will be assumed when p<α=0.05.. Within time: W3-W7 Between groups: EGR versus SGR. The results are shown for all variables in a table. |
Timespad registration: Week 3/intermediate measurement (W3), week 7/ post measurement (W7)
|
|
Third measurment: Quality of life, EQ-5D-3L-index
기간: Timespad registration: Week 0/baseline measurement (W0)- Week 7/ post measurement (W7)
|
The EQ-5D-3L-index will analyze the participants Quality of life (QoL). Each question in the EQ-5D-3L-index includes one dimension of QoL: mobility, self-care, daily activities, pain/discomfort & anxiety/depression. Each dimension has 3 levels ( having no problems, having some or moderate problems, being unable to do/having extreme problems) and gets a separate score.The scores can be combined in combination with an assessment of the health status they represent, this rating is expressed in weight or utility (1,000 = no problems at all) to (-0,329= extreme problems). Description of the QoL can be transformed into a QoL assessment by means of a formula. These ratings are based on judgments of the general population of all possible combinations of QoL on the different dimensions. An improvement in quality of life will be assumed when p<α=0.05. Within time: W0-W7 Between groups: EGR versus SGR. The results are shown for all variables in a table. |
Timespad registration: Week 0/baseline measurement (W0)- Week 7/ post measurement (W7)
|
|
Fourth measurment: Quality of life, EQ-5D-3L-index
기간: Timespad registration: Week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
The EQ-5D-3L-index will analyze the participants Quality of life (QoL). Each question in the EQ-5D-3L-index includes one dimension of QoL: mobility, self-care, daily activities, pain/discomfort & anxiety/depression. Each dimension has 3 levels ( having no problems, having some or moderate problems, being unable to do/having extreme problems) and gets a separate score.The scores can be combined in combination with an assessment of the health status they represent, this rating is expressed in weight or utility (1,000 = no problems at all) to (-0,329= extreme problems). Description of the QoL can be transformed into a QoL assessment by means of a formula. These ratings are based on judgments of the general population of all possible combinations of QoL on the different dimensions. An improvement in quality of life will be assumed when p<α=0.05. Within time: W7-W12 Between groups: EGR versus SGR. The results are shown for all variables in a table. |
Timespad registration: Week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
|
First measurment: EQ- visual analogue scale (VAS)
기간: Time Frame: Timespad registration: Week 0/baseline measurement (W0) - week 3/intermediate measurement (W3)
|
The EQ VAS records the respondent's self-rated health on a 20 cm vertical (0-100 score), visual analogue scale with endpoints labelled 'the best health (100) you can imagine' and 'the worst health you can imagine (0) '.
This information can be used as a quantitative measure of health as judged by the individual respondents.
An improvement in quality of life will be assumed when p<α=0.05.
For the EQ-VAS we used the minimum important change (MIC) for VAS 15 points Within time: W0-W3 Between groups: EGR versus SGR.
The results are shown for all variables in a table.
|
Time Frame: Timespad registration: Week 0/baseline measurement (W0) - week 3/intermediate measurement (W3)
|
|
Second measurment: EQ- visual analogue scale (VAS)
기간: Timespad registration: Week 3/intermediate measurement (W3), week 7/ post measurement (W7)
|
The EQ VAS records the respondent's self-rated health on a 20 cm vertical (0-100 score), visual analogue scale with endpoints labelled 'the best health (100) you can imagine' and 'the worst health you can imagine (0) '.
This information can be used as a quantitative measure of health as judged by the individual respondents.
An improvement in quality of life will be assumed when p<α=0.05.
For the EQ-VAS we used the minimum important change (MIC) for VAS 15 points Within time: W3-W7 Between groups: EGR versus SGR.
The results are shown for all variables in a table.
|
Timespad registration: Week 3/intermediate measurement (W3), week 7/ post measurement (W7)
|
|
Third measurment: EQ- visual analogue scale (VAS)
기간: Timespad registration: Week 0/baseline measurement (W0)- Week 7/ post measurement (W7)
|
The EQ VAS records the respondent's self-rated health on a 20 cm vertical (0-100 score), visual analogue scale with endpoints labelled 'the best health (100) you can imagine' and 'the worst health you can imagine (0) '.
This information can be used as a quantitative measure of health as judged by the individual respondents.
An improvement in quality of life will be assumed when p<α=0.05.
For the EQ-VAS we used the minimum important change (MIC) for VAS 15 points Within time: W0-W7 Between groups: EGR versus SGR.
The results are shown for all variables in a table.
|
Timespad registration: Week 0/baseline measurement (W0)- Week 7/ post measurement (W7)
|
|
Fourth measurment: EQ- visual analogue scale (VAS)
기간: Timespad registration: Week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
The EQ VAS records the respondent's self-rated health on a 20 cm vertical (0-100 score), visual analogue scale with endpoints labelled 'the best health (100) you can imagine' and 'the worst health you can imagine (0) '.
This information can be used as a quantitative measure of health as judged by the individual respondents.
An improvement in quality of life will be assumed when p<α=0.05.
For the EQ-VAS we used the minimum important change (MIC) for VAS 15 points Within time: W7-W12 Between groups: EGR versus SGR.
The results are shown for all variables in a table.
|
Timespad registration: Week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
AROM° thoracolumbar-pelvic flexion (TLPF)
기간: Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
AROM° Thoracolumbar-pelvic flexion. The inclinometer placed on L1 / T12 with the tape between the inclinometer arcus and was set to 0°. During the test, the investigator kept the inclinometer on L1 / T12 while instructing the subject to bend forward with the arms in hanging position. The changes in our variables will be analyzed within time and between groups. Within time: W0-W3, W0-W7, W3-W7, and W7-W12. Between groups: EGR versus SGR. The results are shown for all variables in a table. The analysis for all variables is significant when p<α=0.05. |
Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
|
AROM° thoracolumbar- pelvic extension (TLPE)
기간: Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
AROM° Thoracolumbar-pelvic extension. The inclinometer placed on L1 / T12 with the tape between the inclinometer arcus and was set to 0 °. During the test, the investigator kept the inclinometer on L1 / T12 while instructing the subject to put his hands on his pelvis and bend backward. The changes in our variables will be analyzed within time and between groups. Within time: W0-W3, W0-W7, W3-W7, and W7-W12. Between groups: EGR versus SGR. The results are shown for all variables in a table. The analysis for all variables is significant when p<α=0.05. |
Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
|
AROM° isolated lumbar flexion(ILF)
기간: Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
AROM° Isolated lumbar flexion test. The inclinometer was moved to labeled S1 / S2 and the inclinometer was set to 0 °. During the test, the investigator held the inclinometer on S1 / S2 while instructing the subject to bend forward. The formula ∑▒〖T12/L1〗 - S1/S2 was used. The changes in our variables will be analyzed within time and between groups. Within time: W0-W3, W0-W7, W3-W7, and W7-W12. Between groups: EGR versus SGR. The results are shown for all variables in a table. The analysis for all variables is significant when p<α=0.05. |
Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
|
Pain intensity flexion (0-10)
기간: Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
Before the participant gave a PI number to the active flexion or extension, the VRS scale was shown. Thereafter the movement was performed as described in the protocol. After completing the active flexion or extension, the participant gave a VRS score regarding the PI. The changes in our variables will be analyzed within time and between groups. Within time: W0-W3, W0-W7, W3-W7, and W7-W12. Between groups: EGR versus SGR. The results are shown for all variables in a table. The analysis for all variables is significant when p<α=0.05. |
Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
|
Pain intensity extension (0-10)
기간: Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
. Before the participant gave a PI number to the active flexion or extension, the VRS scale was shown. Thereafter the movement was performed as described in the protocol. After completing the active flexion or extension, the participant gave a VRS score regarding the PI. The changes in our variables will be analyzed within time and between groups. Within time: W0-W3, W0-W7, W3-W7, and W7-W12. Between groups: EGR versus SGR. The results are shown for all variables in a table. The analysis for all variables is significant when p<α=0.05. |
Timespad registration: Week 0/baseline measurement (W0), week 3/intermediate measurement (W3), week 7/ post measurement (W7) and week 12 follow up measurement (W12)
|
공동 작업자 및 조사자
협력자
수사관
- 연구 책임자: Peter P Vaes, PhD, University of Brussels, faculty of Rehabilitation science and physical therapy, faculty of Pharmacy and medicine, Brussels, Belgium
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
삶의 질에 대한 임상 시험
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)완전한
-
Queens College, The City University of New York모병
-
Swansea University완전한A Bite of ACT' (BOA) 수용전념치료 온라인 심리교육 과정 | 대기자 명단 제어영국
-
Hôpital Léon Bérard완전한
-
Yale-NUS College완전한연구 초점은 SGH Life Center에서 관리하는 비만 관리 설문지에 대한 환자의 반응입니다.싱가포르
-
Scripps Translational Science Institute완전한
-
Novartis Pharmaceuticals완전한신경내분비종양 | GI 오리진의 고급 NET | 고급 NET of Lung Origin미국, 콜롬비아, 이탈리아, 대만, 영국, 벨기에, 체코, 독일, 일본, 사우디 아라비아, 캐나다, 네덜란드, 스페인, 대한민국, 레바논, 오스트리아, 중국, 그리스, 남아프리카, 태국, 헝가리, 칠면조, 폴란드, 슬로바키아, 러시아 연방
-
Yale-NUS College완전한
-
University Hospital Inselspital, BerneDeka Medical, Inc.모집하지 않고 적극적으로
-
University of Pennsylvania완전한Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410의 주진단 또는 이차진단 코드가 있는 환자(5번째 숫자가 2인 경우 제외)미국
물리 치료 중재에 대한 임상 시험
-
VA Office of Research and Development모집하지 않고 적극적으로
-
Washington University School of MedicineSt. Jude Children's Research Hospital완전한
-
University of MichiganNational Institute on Drug Abuse (NIDA)모병
-
University of MichiganNational Institute of Nursing Research (NINR)완전한
-
RTI InternationalUniversity of North Carolina, Chapel Hill초대로 등록결절성 경화증 | 다운 증후군 | 뒤시엔 근이영양증 | 프래더-윌리 증후군 | 취약 X 증후군 | 레트 증후군 | 터너 증후군 | 윌리엄스 증후군 | 엔젤만 증후군 | 염색체 22q11.2 결실 증후군 | 클라인펠터 증후군 | 펠란-맥더미드 증후군 | Dup15Q 증후군 | 스미스 마제니스 증후군미국
-
University of MichiganNational Center for Advancing Translational Sciences (NCATS)완전한